Simplified digitalis-like compounds acting on Na(+), K(+)-ATPase

¹Department of Medicinal Chemistry, Prassis Istituto di Ricerche Sigma-Tau, Via Forlanini 3, 20019 Settimo Milanese, MI, Italy. alberto.cerri@prassis.it

Journal of Enzyme Inhibition and Medicinal Chemistry

|October 22, 2003

Summary

Researchers explored safer digitalis compounds for heart failure treatment by simplifying their structure. Minor modifications preserved heart-boosting effects, but significant simplification reduced potency.

Area of Science:

Medicinal Chemistry
Pharmacology
Cardiovascular Science

Background:

Digitalis compounds are vital positive inotropic agents for congestive heart failure, primarily by inhibiting Na(+),K(+)-ATPase.
A significant limitation of digitalis is its arrhythmogenic potential, necessitating the search for safer alternatives.

Purpose of the Study:

To review molecular simplifications of the digitalis steroidal skeleton (1990-2002) aimed at developing safer, effective cardiac drugs.
To elucidate the structural requirements for binding to the Na(+),K(+)-ATPase target site.

Main Methods:

Review of medicinal chemistry literature focusing on digitalis compound modifications.
Analysis of structure-activity relationships for simplified digitalis-like molecules.

Main Results:

Minor structural simplifications, such as D-ring cleavage, retained positive inotropic activity.
Highly simplified compounds, even with potent pharmacophores, exhibited insufficient inotropic potency.

Conclusions:

Understanding the digitalis binding site on Na(+),K(+)-ATPase is crucial for designing safer and effective positive inotropic agents.
Structural integrity of the digitalis skeleton is important for maintaining therapeutic efficacy, with significant simplification leading to loss of potency.

Related Experiment Videos

Simplified digitalis-like compounds acting on Na(+), K(+)-ATPase

Related Concept Videos

Novel analogues of Istaroxime, a potent inhibitor of Na(+),K(+)-ATPase: Synthesis, structure-activity relationship and 3D-quantitative structure-activity relationship of derivatives at position 6 on the androstane scaffold.

Novel analogues of istaroxime, a potent inhibitor of Na+,K+-ATPase: synthesis and structure-activity relationship.

Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).

Digitalis-like compounds: the discovery of the O-aminoalkyloxime group as a very powerful substitute for the unsaturated gamma-butyrolactone moiety.

Structure-based design and synthesis of novel potent Na+,K+ -ATPase inhibitors derived from a 5alpha,14alpha-androstane scaffold as positive inotropic compounds.

Synthesis and inotropic activity of 1-(O-aminoalkyloximes) of perhydroindene derivatives as simplified digitalis-like compounds acting on the Na(+),K(+)-ATPase.

Structure-based screening and identification of a novel Aurora-A-targeting peptide with antiproliferative activity against prostate cancer cells.

Design, synthesis, and stability evaluation of semaglutide-derived lactam-stapled peptide scaffolds for GLP-1R targeting.

Recent progress in small molecules targeting the acidic tumor microenvironment.

Context matters in PROTAC design: navigating the trade-off between degradation and developability.

Solvent-controlled Rh-catalysed hydrodehalogenation and construction of phenanthridinone skeleton from a common precursor in one-step sequence and the antitumor activity of its derivatives.

Virtual screening and experimental validation of a METTL3-targeting peptide with in vitro antiproliferative activity against non-small cell lung cancer cells.

Avoiding pitfalls when modelling ligands in macromolecular crystallography.

Dual targeting of VEGFR-2 and FAK kinases by novel benzimidazole-oxadiazole hybrids: a potential approach in cancer therapy.

Quantum dot (QD)-based silicon as an efficient catalyst for the one-pot synthesis of polynuclear acridines: molecular docking investigation of putative anti-tubercular and anti-HIV drug candidates.

Mechanistic insights into daidzin from Glycine max against breast cancer via network pharmacology and multi-level molecular modeling.

A report on the mechanisms of sweeteners in four musculoskeletal disorders: Insights from network toxicology, molecular docking, and molecular dynamics simulations.

Related Experiment Videos

Simplified digitalis-like compounds acting on Na(+), K(+)-ATPase

Area of Science:

Background:

Purpose of the Study:

Main Methods:

Main Results:

Conclusions:

Related Concept Videos

Related Articles